German 'hypervaccinator' gets 217 coronavirus shots; researchers find no ill effects, good immune response
- News & Current Events (Articles Required)
- 79 Replies
German researchers have examined a “hypervaccinated” man they say received more than 200 coronavirus shots without any noticeable side effects or harm to his immune system.
Their findings, published Monday in the Lancet Infectious Diseases, a medical journal, indicate that coronavirus vaccines have a “good degree of tolerability,” the researchers said, although they noted this was an isolated case of “extraordinary hypervaccination.”
“We learned about his case via newspaper articles,” Kilian Schober, one of the study’s authors, said in a statement. “We then contacted him and invited him to undergo various tests. … He was very interested in doing so.”
Going into the study, the researchers had speculated that having so many shots could cause his immune system to become fatigued.
But in fact, the researchers found that the man had more of these immune cells — known as T-cells — than a control group that had received the standard three-dose vaccine regimen. They also did not detect any fatigue in these cells, which they said were just as effective as those of people who had received a typical number of coronavirus shots.
The researchers made it clear that despite their findings, they “do not endorse hypervaccination as a strategy to enhance adaptive immunity.”
Their findings, published Monday in the Lancet Infectious Diseases, a medical journal, indicate that coronavirus vaccines have a “good degree of tolerability,” the researchers said, although they noted this was an isolated case of “extraordinary hypervaccination.”
“We learned about his case via newspaper articles,” Kilian Schober, one of the study’s authors, said in a statement. “We then contacted him and invited him to undergo various tests. … He was very interested in doing so.”
Going into the study, the researchers had speculated that having so many shots could cause his immune system to become fatigued.
But in fact, the researchers found that the man had more of these immune cells — known as T-cells — than a control group that had received the standard three-dose vaccine regimen. They also did not detect any fatigue in these cells, which they said were just as effective as those of people who had received a typical number of coronavirus shots.
The researchers made it clear that despite their findings, they “do not endorse hypervaccination as a strategy to enhance adaptive immunity.”